Ramsay Generale dente (XPAR:GDS) ROCE %: 0.00% (As of Dec. 2025)


XPAR:GDS Ramsay Generale de Sante SA XPAR:GDS
71 GF Score
Price €11.30
GF Value €21.72
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Ramsay Generale dente ROCE %?

Ramsay Generale dente XPAR:GDS -1.31% 71 ROCE % is 0.00% as of Dec. 2025. GuruFocus rates XPAR:GDS with a GF Score™ of 71/100 and a GF Value™ of €21.72 (Possible Value Trap). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ramsay Generale dente's annualized ROCE % for the quarter that ended in Dec. 2025 was 0.00%.


Ramsay Generale dente  (XPAR:GDS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Ramsay Generale dente ROCE % Related Terms


Ramsay Generale dente ROCE % Historical Data

* Premium members only.

The historical data trend for Ramsay Generale dente's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Generale dente ROCE % Chart

Ramsay Generale dente Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.39 5.75 4.50 2.96 3.11

Ramsay Generale dente Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 8.55 8.88 0.00 5.06
XPAR:GDS
71GF Score
Ramsay Generale de Sante SA XPAR:GDS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Generale dente ROCE % Calculation

Ramsay Generale dente's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=162/( ( (6895.2 - 1686) + (6839 - 1617.4) )/ 2 )
=162/( (5209.2+5221.6)/ 2 )
=162/5215.4
=3.11 %

Ramsay Generale dente's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=0/( ( (6839 - 1617.4) + (6579.2 - 1409.5) )/ 2 )
=0/( ( 5221.6 + 5169.7 )/ 2 )
=0/5195.65
=0.00 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Ramsay Generale dente (XPAR:GDS) has a ROCE % of 0.00% as of Dec. 2025.
Is Ramsay Generale dente's ROCE % too high?
Ramsay Generale dente's current ROCE % is 0.00%. Overall, Ramsay Generale dente has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's ROCE % compare to HCA and THC?
Ramsay Generale dente's ROCE % of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Generale dente's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Generale dente (XPAR:GDS) is currently considered Possible Value Trap. The stock's GF Value™ is €21.72, compared to a current price of €11.30 — trading 48% below its estimated fair value. The current ROCE % is 0.00%. Ramsay Generale dente's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ramsay Generale dente (XPAR:GDS), the current ROCE % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramsay Generale dente (XPAR:GDS) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued. The current stock price of €11.30 is trading 48% below its estimated GF Value™ of €21.72. GuruFocus considers Ramsay Generale dente to be Possible Value Trap.

Key valuation signals for XPAR:GDS:

  • ROCE %: 0.00%
  • GF Value™: €21.72 vs. price of €11.30 (48% below fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the XPAR:GDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ramsay Generale dente Business Description

Other Exchanges 0OD6:UKGD6:Germany
Address 39 Rue Mstislav, Rostropovitch, Paris, FRA, 75017
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score

Get the complete analysis for XPAR:GDS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.30
Price
€21.72
GF Value